United States

SHAREHOLDER ALERT: Holzer & Holzer, LLC Reminds Investors of the October 21, 2024 Lead Plaintiff Deadline in Class Action Lawsuits Filed on Behalf of DexCom, Inc. (DXCM), Orthofix Medical Inc. (OFIX), and Spire Global, Inc. (SPIR) Shareholders

ATLANTA, Oct. 17, 2024 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the October 21, 2024 Lead Plaintiff deadline in the following class action lawsuits.

DexCom, Inc.

A shareholder class action lawsuit has been filed against DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM). The lawsuit alleges that Defendants created the false impression that they possessed reliable information pertaining to the Company’s projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations. Such statements are alleged to have caused Plaintiff and other shareholders to purchase DexCom’s securities at artificially inflated prices.

If you bought shares of DexCom between January 8, 2024 and July 25, 2024, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/dexcom/ to learn more.

Orthofix Medical Inc.

A shareholder class action lawsuit has been filed against Orthofix Medical Inc. (“Orthofix” or “the Company”) (NASDAQ: OFIX). The lawsuit alleges that Orthofix’s management team was engaged in “repeated inappropriate and offensive conduct that violated multiple code of conduct requirements,” which was “inconsistent with the Company’s values and culture.” When the truth about the Company’s management team was revealed, the price of Orthofix common stock suffered sharp declines.

If you bought shares of Orthofix between October 11, 2022 and September 12, 2023, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/orthofix-medical/ to learn more.

Spire Global, Inc.

A shareholder class action lawsuit has been filed against Spire Global, Inc. (“Spire Global” or the “Company”) (NYSE: SPIR). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts regarding the Company’s business, operations, and prospects, including allegations that: (1) there were embedded leases of identifiable assets and pre-space mission activities for certain Space Services contracts; (2) Spire Global lacked effective internal controls regarding revenue recognition for these contracts; and (3) as a result, Spire Global overstated revenue for certain Space Services contracts.

If you bought shares of Spire Global between May 11, 2022 and August 27, 2024, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at http://holzerlaw.com/case/spire-global/ to learn more.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, https://holzerlaw.com/, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.  

CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker